Advanz Pharma Corporation Ltd. (CXRXF)
Jun 11, 2021 - CXRXF was delisted (reason: acquired by Nordic Capital)
Stock Price: $17.06 USD
0.00 (0.00%)
Updated Jun 10, 2021 9:30 AM EDT
| Market Cap | 834.46M |
| Revenue (ttm) | 531.70M |
| Net Income (ttm) | n/a |
| Shares Out | 48.91M |
| EPS (ttm) | -1.66 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | Aug 3, 2021 |
| Last Price | $17.06 |
| Previous Close | $17.06 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 17.06 |
| Day's Range | 17.06 - 17.06 |
| Day's Volume | 0 |
| 52-Week Range | 2.13 - 17.50 |
News
There are no news available yet.
About CXRXF
ADVANZ PHARMA Corp. Limited, a pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products worldwide. The company operates through two segments: ADVANZ PHARMA International and ADVANZ PHARMA North America. Its ADVANZ PHARMA International segment offers a portfolio of branded and generic prescription products to wholesalers, distributors, hospitals, and pharmacies. This segment's products include Brinavess for the conversion of onset atrial fibrillation to sinus rhythm in adults; Ag... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| CEO Graeme Neville Duncan | Country United Kingdom |
| Stock Exchange OTCMKTS | Ticker Symbol CXRXF |